Apogee Therapeutics, Inc. (APGE)
Across 11 earnings reports since Aug 28, 2023, Apogee Therapeutics, Inc. (APGE) has a clear post-earnings pattern. It moves ±7.36% on average after reporting and finishes higher 54.5% of the time. Its largest post-earnings gain was +42.07% (Mar 05, 2024) and its largest decline was -5.14% (Nov 12, 2024). The next earnings report is predicted for 2026-08-12 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
11
Avg Abs. Movement
±7.36%
Positive %
54.5%
Negative %
45.5%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | ☀ PRE | $85.93 | $88.27 | $84.54 | 31,434 | +1.81% | open_in_new |
| Nov 10, 2025 | ☀ PRE | $56.20 | $57.53 | $56.77 | 462,800 | +3.77% | open_in_new |
| Aug 11, 2025 | ☀ PRE | $35.39 | $35.74 | $34.65 | 467,800 | -2.09% | open_in_new |
| May 12, 2025 | ☀ PRE | $39.49 | $40.70 | $39.58 | 705,500 | +6.14% | open_in_new |
| Mar 03, 2025 | ☀ PRE | $32.66 | $35.20 | $31.39 | 1,084,300 | -0.16% | open_in_new |
| Nov 12, 2024 | ☀ PRE | $60.24 | $61.05 | $57.35 | 288,000 | -5.14% | open_in_new |
| Aug 12, 2024 | ☀ PRE | $39.98 | $44.99 | $44.46 | 567,200 | +9.78% | open_in_new |
| May 13, 2024 | ☀ PRE | $54.07 | $54.96 | $52.73 | 296,300 | -0.92% | open_in_new |
| Mar 05, 2024 | ☀ PRE | $59.91 | $65.41 | $59.30 | 6,358,100 | +42.07% | open_in_new |
| Nov 13, 2023 | ☀ PRE | $14.91 | $16.30 | $16.28 | 347,200 | +7.32% | open_in_new |
| Aug 28, 2023 | ☀ PRE | $23.56 | $23.82 | $23.33 | 169,200 | -1.77% | open_in_new |
Earnings Count
11
Total earnings in dataset
Avg Abs. Movement
±7.36%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260605 | open_in_new SEC.gov |
| 8-K | 20260527 | open_in_new SEC.gov |
| 8-K | 20260527 | open_in_new SEC.gov |
| 4 | 20260515 | open_in_new SEC.gov |
| 144 | 20260513 | open_in_new SEC.gov |
| 4 | 20260508 | open_in_new SEC.gov |
| 144 | 20260506 | open_in_new SEC.gov |
| 4 | 20260504 | open_in_new SEC.gov |
| 144 | 20260501 | open_in_new SEC.gov |
| DEFA14A | 20260424 | open_in_new SEC.gov |
Frequently asked about APGE earnings
When does Apogee Therapeutics, Inc. report earnings next? expand_more
Apogee Therapeutics, Inc. (APGE)'s next earnings date is estimated for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does APGE stock move after earnings? expand_more
Over 11 reports, APGE has moved an average of ±7.36% the session after earnings, closing higher 54.5% of the time.
What was APGE's biggest post-earnings move? expand_more
APGE's largest post-earnings gain on record was +42.07% on Mar 05, 2024, and its largest decline was -5.14% on Nov 12, 2024.
Where can I find Apogee Therapeutics, Inc.'s SEC filings? expand_more
All of Apogee Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right